Specialty Chemicals company Kiri Industries announced Q3FY25 results Consolidated revenues were Rs 281.25 crore, reflecting an 27% YoY growth and a 3% QoQ rise. Consolidated EBIDTA for Q3FY25 was Rs -8.39 crore reflecting negative earnings by 2.8% QoQ due to higher expenditure towards legal fees pertaining to DyStar Case. Kiri’s standalone revenue for Q3FY25 was Rs156.38 crore marking an increase by 8% YoY and 11% QoQ. The Standalone EBIDTA for Q3FY25 was positive Rs 37.40 crore. Result PDF